Works by Harousseau, Jean-Luc


Results: 80
    1
    2

    Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.

    Published in:
    European Journal of Haematology, 2012, v. 88, n. 3, p. 249, doi. 10.1111/j.1600-0609.2011.01729.x
    By:
    • Yakoub-Agha, Ibrahim;
    • Mary, Jean-Yves;
    • Hulin, Cyrille;
    • Doyen, Chantal;
    • Marit, Gérald;
    • Benboubker, Lotfi;
    • Voillat, Laurent;
    • Moreau, Philippe;
    • Berthou, Christian;
    • Stoppa, Anne-Marie;
    • Maloisel, Frédéric;
    • Rodon, Philippe;
    • Dib, Mamoun;
    • Pegourie, Brigitte;
    • Casassus, Philippe;
    • Slama, Borhane;
    • Damaj, Ghandi;
    • Zerbib, Robert;
    • Harousseau, Jean-Luc;
    • Mohty, Mohamad
    Publication type:
    Article
    3

    Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.

    Published in:
    European Journal of Haematology, 2007, v. 79, n. 4, p. 297, doi. 10.1111/j.1600-0609.2007.00915.x
    By:
    • Gastinne, Thomas;
    • Leleu, Xavier;
    • Duhamel, Alain;
    • Moreau, Anne-Sophie;
    • Franck, Genevieve;
    • Andrieux, Joris;
    • Lai, Jean-Luc;
    • Coiteux, Valerie;
    • Yakoub-Agha, Ibrahim;
    • Bauters, Francis;
    • Harousseau, Jean-Luc;
    • Zandecki, Marc;
    • Facon, Thierry
    Publication type:
    Article
    4
    5
    6
    7
    8

    Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: A GOELAMS study.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 12, p. 1052, doi. 10.1002/ajh.23311
    By:
    • Guièze, Romain;
    • Cornillet-Lefebvre, Pascale;
    • Lioure, Bruno;
    • Blanchet, Odile;
    • Pigneux, Arnaud;
    • Recher, Christian;
    • Bonmati, Caroline;
    • Fegueux, Nathalie;
    • Bulabois, Claude-Eric;
    • Bouscary, Didier;
    • Vey, Norbert;
    • Delain, Martine;
    • Turlure, Pascal;
    • Himberlin, Chantal;
    • Harousseau, Jean-Luc;
    • Dreyfus, Francois;
    • Béné, Marie C.;
    • Ifrah, Norbert;
    • Chevallier, Patrice
    Publication type:
    Article
    9

    Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective.

    Published in:
    Oncologist, 2011, v. 16, n. 4, p. 388, doi. 10.1634/theoncologist.2010-0386
    By:
    • LUDWIG, HEINZ;
    • BEKSAC, MERAL;
    • BLADÉ, JOAN;
    • CAVENAGH, JAMIE;
    • CAVO, MICHELE;
    • DELFORGE, MICHEL;
    • DIMOPOULOS, MELETIOS;
    • DRACH, JOHANNES;
    • EINSELE, HERMANN;
    • FACON, THIERRY;
    • GOLDSCHMIDT, HARTMUT;
    • HAROUSSEAU, JEAN-LUC;
    • HESS, URS;
    • KROPFF, MARTIN;
    • DA COSTA, FERNANDO LEAL;
    • LOUW, VERNON;
    • MAGEN-NATIV, HILA;
    • MENDELEEVA, LARISA;
    • NAHI, HARETH;
    • PLESNER, TORBEN
    Publication type:
    Article
    10

    Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective.

    Published in:
    Oncologist, 2010, v. 15, n. 1, p. 6, doi. 10.1634/theoncologist.2009-0203
    By:
    • LUDWIG, HEINZ;
    • BEKSAC, MERAL;
    • BLADÉ, JOAN;
    • BOCCADORO, MARIO;
    • CAVENAGH, JAMIE;
    • CAVO, MICHELE;
    • DIMOPOULOS, MELETIOS;
    • DRACH, JOHANNES;
    • EINSELE, HERMANN;
    • FACON, THIERRY;
    • GOLDSCHMIDT, HARTMUT;
    • HAROUSSEAU, JEAN-LUC;
    • HESS, URS;
    • KETTERER, NICOLAS;
    • KROPFF, MARTIN;
    • MENDELEEVA, LARISA;
    • MORGAN, GARETH;
    • PALUMBO, ANTONIO;
    • PLESNER, TORBEN;
    • MIGUEL, JESÚS SAN
    Publication type:
    Article
    11
    12
    13
    14
    15

    Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma.

    Published in:
    Leukemia & Lymphoma, 2010, v. 51, n. 8, p. 1502, doi. 10.3109/10428194.2010.497981
    By:
    • Clavert, Aline;
    • Le Gouill, Steven;
    • Brissot, Eolia;
    • Dubruille, Viviane;
    • Mahe, Beatrice;
    • Gastinne, Thomas;
    • Blin, Nicolas;
    • Chevallier, Patrice;
    • Guillaume, Thierry;
    • Delaunay, Jacques;
    • Ayari, Sameh;
    • Saulquin, Beatrice;
    • Moreau, Anne;
    • Moreau, Philippe;
    • Harousseau, Jean-Luc;
    • Milpied, Noel;
    • Mohty, Mohamad
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    A Multicentric Randomised Study of Alpha 2b Interferon (IFN) and Hydroxyurea (HU) with or without Cytosine-Arabinoside (Ara-c) in Previously Untreated Patients with Ph++ Chronic Myelocytic Leukemia (CML): Preliminary Cytogenetic Results.

    Published in:
    Leukemia & Lymphoma, 1993, v. 11, n. s1, p. 181, doi. 10.3109/10428199309047883
    By:
    • Guilhot, Francois;
    • Abgrall, Jean-Francois;
    • Harousseau, Jean-Luc;
    • Bauters, Francis;
    • Brice, Pauline;
    • Dine, Gerard;
    • Tilly, Herve;
    • Ifrahy, Norbert;
    • Cassasus, Philippe;
    • Rochant, Henri;
    • Christian, Bernard;
    • Guerci, Agnes;
    • Lamagnere, Jean-Pierre;
    • Prise, Pierre-Yves Le;
    • Duclos, Brigitte;
    • Tanzer, Joseph
    Publication type:
    Article
    22
    23
    24
    25

    Monoclonal gammopathy of undetermined significance: a consensus statement.

    Published in:
    British Journal of Haematology, 2010, v. 150, n. 1, p. 28, doi. 10.1111/j.1365-2141.2010.08207.x
    By:
    • Berenson, James R.;
    • Anderson, Kenneth C.;
    • Audell, Robert A.;
    • Boccia, Ralph V.;
    • Coleman, Morton;
    • Dimopoulos, Meletios A.;
    • Drake, Matthew T.;
    • Fonseca, Rafael;
    • Harousseau, Jean-Luc;
    • Joshua, Douglas;
    • Lonial, Sagar;
    • Niesvizky, Ruben;
    • Palumbo, Antonio;
    • Roodman, G. David;
    • San-Miguel, Jesus F.;
    • Singhal, Seema;
    • Weber, Donna M.;
    • Zangari, Maurizio;
    • Wirtschafter, Eric;
    • Yellin, Ori
    Publication type:
    Article
    26
    27

    Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.

    Published in:
    British Journal of Haematology, 2009, v. 144, n. 6, p. 895, doi. 10.1111/j.1365-2141.2008.07573.x
    By:
    • Richardson, Paul G.;
    • Sonneveld, Pieter;
    • Schuster, Michael W.;
    • Stadtmauer, Edward A.;
    • Facon, Thierry;
    • Harousseau, Jean-Luc;
    • Ben-Yehuda, Dina;
    • Lonial, Sagar;
    • Goldschmidt, Hartmut;
    • Reece, Donna;
    • Blad, Joan;
    • Boccadoro, Mario;
    • Cavenagh, Jamie D.;
    • Boral, Anthony L.;
    • Esseltine, Dixie-Lee;
    • Wen, Patrick Y.;
    • Amato, Anthony A.;
    • Anderson, Kenneth C.;
    • San Miguel, Jesus
    Publication type:
    Article
    28
    29
    30

    The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma.

    Published in:
    British Journal of Haematology, 2008, v. 143, n. 1, p. 46, doi. 10.1111/j.1365-2141.2008.07303.x
    By:
    • Niesvizky, Ruben;
    • Richardson, Paul G.;
    • Rajkumar, S. Vincent;
    • Coleman, Morton;
    • Rosiñol, Laura;
    • Sonneveld, Pieter;
    • Schuster, Michael W.;
    • Irwin, David;
    • Stadtmauer, Edward A.;
    • Facon, Thierry;
    • Harousseau, Jean-Luc;
    • Boral, Anthony L.;
    • Esseltine, Dixie-Lee;
    • Anderson, Kenneth C.;
    • Blad, Joan
    Publication type:
    Article
    31
    32

    Lack of CD27 in myeloma delineates different presentation and outcome.

    Published in:
    British Journal of Haematology, 2006, v. 132, n. 2, p. 168, doi. 10.1111/j.1365-2141.2005.05849.x
    By:
    • Moreau, Philippe;
    • Robillard, Nelly;
    • Jégo, Gaétan;
    • Pellat, Catherine;
    • Gouill, Steven Le;
    • Thoumi, Soraya;
    • Avet-Loiseau, Herv;
    • Harousseau, Jean-Luc;
    • Bataille, Régis
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39

    P53 deletion is not a frequent event in multiple myeloma.

    Published in:
    British Journal of Haematology, 1999, v. 106, n. 3, p. 717, doi. 10.1046/j.1365-2141.1999.01615.x
    By:
    • Avet-Loiseau, Hervé;
    • Li, Jian-Yong;
    • Godon, Catherine;
    • Morineau, Nadine;
    • Daviet, Axelle;
    • Harousseau, Jean-Luc;
    • Facon, Thierry;
    • Bataille, Régis
    Publication type:
    Article
    40
    41

    Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients.

    Published in:
    British Journal of Haematology, 1998, v. 101, n. 4, p. 766, doi. 10.1046/j.1365-2141.1998.00772.x
    By:
    • Moreau, Philippe;
    • Leblond, Véronique;
    • Bourquelot, Priscille;
    • Facon, Thierry;
    • Huynh, Anne;
    • Caillot, Denis;
    • Hermine, Olivier;
    • Attal, Michel;
    • Hamidou, Mohamed;
    • Nedellec, Gérard;
    • Ferrant, Augustin;
    • Audhuy, Bruno;
    • Bataille, Régis;
    • Milpied, Noël;
    • Harousseau, Jean-Luc
    Publication type:
    Article
    42
    43
    44
    45

    A pilot study of 220 mg/m.

    Published in:
    British Journal of Haematology, 1996, v. 95, n. 3, p. 527, doi. 10.1046/j.1365-2141.1996.d01-1932.x
    By:
    • Moreau, Philippe;
    • Kergueris, Marie-France;
    • Milpied, NoE¨l;
    • Le Tortorec, Stéphane;
    • Mahé, Béatrice;
    • Bulabois, Claude-Eric;
    • Rapp, Marie-JosÉ;
    • Larousse, Claude;
    • Bataille, RÉgis;
    • Harousseau, Jean-Luc
    Publication type:
    Article
    46

    CYTOKINE THERAPY IN MULTIPLE MYELOMA*.

    Published in:
    British Journal of Haematology, 1996, v. 94, n. 3, p. 425, doi. 10.1046/j.1365-2141.1996.02298.x
    By:
    • PEEST, DIETRICH;
    • BLADÉ, JOAN;
    • HAROUSSEAU, JEAN-LUC;
    • KLEIN, BERNHARD;
    • ÖSTERBORG, ANDERS;
    • SAN MIGUEL, JESUS F.
    Publication type:
    Article
    47
    48

    Prognostic impact of <sup>18</sup>F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 9, p. 1633, doi. 10.1007/s00259-010-1469-2
    By:
    • Bodet-Milin, Caroline;
    • Touzeau, Cyrille;
    • Leux, Christophe;
    • Sahin, Mehmet;
    • Moreau, Anne;
    • Maisonneuve, Hervé;
    • Morineau, Nadine;
    • Jardel, Henry;
    • Gallazini-Crépin, Céline;
    • Gries, Pascal;
    • Gressin, Rémy;
    • Harousseau, Jean-Luc;
    • Mohty, Mohamad;
    • Moreau, Philippe;
    • Kraeber-Bodere, Françoise;
    • Le Gouill, Steven
    Publication type:
    Article
    49
    50